# Alaa Halawa

> Alaa Halawa is the co-founder and CEO of Salma Health and an investment executive at Mubadala Capital. An electrical engineering graduate of the University of Jordan with an MBA from Cornell University, he worked in telecommunications and semiconductor strategy before helping establish Mubadala’s San Francisco ventures business. His career spans Globitel, GlobalFoundries, Synaptics, venture investing, board service and company formation.

- **Role:** CEO and co-founder at Salma Health
- **Organizations:** Salma Health, Mubadala Capital, Globitel, GlobalFoundries, Synaptics, Neumora Therapeutics, Innovaccer, Xilis, Pretzel Therapeutics, Alloy Therapeutics, Flare Capital Partners, Altitude Lab Investor Coalition
- **Education:** Undergraduate degree in electrical engineering, University of Jordan, Master of Business Administration, Cornell University
- **Known for:** Helped develop Mubadala’s semiconductor technology-cluster strategy in Abu Dhabi., Helped establish Mubadala Capital’s San Francisco ventures business., Led investments including Recursion, Innovaccer, Insitro and Alloy Therapeutics, as listed by Mubadala Capital.

## Career timeline

- **Early career** — Worked at Globitel, first managing data-center rack installation and later overseeing product lines.
- **2009** — Joined Mubadala and worked on a semiconductor technology cluster in Abu Dhabi.
- **2011** — Moved to Silicon Valley for an initially six-month assignment supporting an executive transition.
- **2014-01–2015-02** — Served as a director at GlobalFoundries; this was an employment role, not an asserted board seat.
- **2015-02–2017-03** — Served as a director at Synaptics.
- **2016** — Completed his Cornell MBA and began laying the groundwork for Mubadala’s ventures business.
- **2017-03** — Began serving as executive director at Mubadala Capital.
- **2021-06** — Named a founding investor in Altitude Lab’s Investor Coalition.
- **2022-09** — Joined Neumora’s board of directors.
- **2024-10** — Began serving as co-founder, CEO and board member of Salma Health.
- **2026-02** — Salma Health announced its public launch and an $80 million Series A co-led by Mubadala Capital and ARCH Venture Partners.

## Achievements

- Helped develop Mubadala’s semiconductor technology-cluster strategy in Abu Dhabi.
- Helped establish Mubadala Capital’s San Francisco ventures business.
- Led investments including Recursion, Innovaccer, Insitro and Alloy Therapeutics, as listed by Mubadala Capital.
- Co-founded Salma Health and became its CEO in October 2024.
- Joined Altitude Lab’s founding investor coalition in 2021.

## Latest updates

- **2026-04** — Neumora’s annual proxy confirmed his continuing Salma Health CEO and board roles, held since October 2024, alongside his Mubadala Capital executive role.
- **2026-02** — Salma Health publicly launched and announced an $80 million Series A co-led by Mubadala Capital and ARCH Venture Partners.

## Links

- LinkedIn: https://www.linkedin.com/in/alaahalawa/
- Twitter/X: https://twitter.com/techalaa

---

Profile page: https://yespress.io/alaa-halawa
Published by YesPress — https://yespress.io
Last updated: 2026-10-22